Back to 
Susquehanna International Group, LLP
Susquehanna International Group, LLP
XERS
Showing 0 of 11 quarters
Position history for Susquehanna International Group, LLP's holdings in Xeris Biopharma Holdings, Inc.
As of its Q3 2021 13F, Susquehanna International Group held 609,527 shares of XERS, worth $1.5M. Susquehanna International Group's 13F filings listed XERS from Q2 2021 to Q3 2021, 2 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.